Product Information
CICLOPIROX 8% SOLUTION is a generic product labeled by Encube Ethicals, Inc., priced at $1.1541 per ML under NDC 21922005351. Its NADAC has been published 142 times since Jan 17, 2024.
FDA first approved this application on Sep 18, 2007. Its Orange Book therapeutic-equivalence code is AT.
Strength
80 mg/mL
Manufacturer
Encube Ethicals, Inc.NDC
21922005351
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CICLOPIROXApproval Type
Generic (ANDA)
FDA Application
ANDA077687FDA Approved
9/18/2007
TE Code
AT
On Market Since
11/9/2023
Pharmacological Classes
Price Statistics
The NADAC for CICLOPIROX 8% SOLUTION has been published 142 times since Jan 17, 2024, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1541 per ML |
|---|---|
| All-time high | $2.0879 (Apr 10, 2024) |
| All-time low | $1.1541 (Sep 23, 2026) |
| 52-week high | $1.4170 |
| 52-week low | $1.1541 |
| Median price | $1.4170 |
| Average price | $1.4810 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 142 |
| Tracking since | Jan 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ciclopirox market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ciclopirox market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CICLOPIROX 8% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CICLOPIROX 8% SOLUTION, manufactured by Encube Ethicals, Inc., is $1.1541 per ML (NDC 21922005351), effective Sep 30, 2026.
How has the price of CICLOPIROX 8% SOLUTION changed over time?
Over the history we have for it, the NADAC for CICLOPIROX 8% SOLUTION has declined 42.4%. It has been tracked across 142 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for CICLOPIROX 8% SOLUTION?
Since Jan 17, 2024, the NADAC for CICLOPIROX 8% SOLUTION has ranged from a low of $1.1541 (Sep 23, 2026) to a high of $2.0879 (Apr 10, 2024), with a median of $1.4170 per ML.
Are there cheaper alternatives to CICLOPIROX 8% SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of CICLOPIROX 8% SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CICLOPIROX 8% SOLUTION?
CICLOPIROX 8% SOLUTION (NDC 21922005351) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.